ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 42 filers reported holding ELOXX PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $8,000 | -38.5% | 46,703 | -0.0% | 0.00% | – |
Q2 2022 | $13,000 | -50.0% | 46,706 | +0.1% | 0.00% | – |
Q1 2022 | $26,000 | -21.2% | 46,672 | +0.0% | 0.00% | – |
Q4 2021 | $33,000 | -8.3% | 46,670 | +118.4% | 0.00% | – |
Q3 2021 | $36,000 | -16.3% | 21,370 | -0.4% | 0.00% | – |
Q2 2021 | $43,000 | -2.3% | 21,455 | +63.8% | 0.00% | – |
Q1 2021 | $44,000 | -70.9% | 13,098 | -65.4% | 0.00% | – |
Q4 2020 | $151,000 | +101.3% | 37,814 | +31.2% | 0.00% | – |
Q3 2020 | $75,000 | -31.2% | 28,824 | -19.9% | 0.00% | – |
Q2 2020 | $109,000 | +142.2% | 35,968 | +56.5% | 0.00% | – |
Q1 2020 | $45,000 | -80.9% | 22,983 | -28.0% | 0.00% | – |
Q4 2019 | $235,000 | +32.0% | 31,920 | -18.6% | 0.00% | – |
Q3 2019 | $178,000 | -55.1% | 39,207 | -1.4% | 0.00% | – |
Q2 2019 | $396,000 | -19.8% | 39,774 | -6.0% | 0.00% | – |
Q1 2019 | $494,000 | +12.8% | 42,302 | +16.1% | 0.00% | – |
Q4 2018 | $438,000 | +128.1% | 36,434 | +224.2% | 0.00% | – |
Q3 2018 | $192,000 | +9.1% | 11,237 | +9.0% | 0.00% | – |
Q2 2018 | $176,000 | – | 10,310 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 1,930,092 | $1,363,000 | 0.55% |
AMERICAN FINANCIAL GROUP INC | 1,480,000 | $1,045,000 | 0.29% |
Vanguard Capital Wealth Advisors | 158,900 | $111,000 | 0.08% |
Anson Funds Management LP | 553,652 | $391,000 | 0.04% |
Nantahala Capital Management | 894,659 | $632,000 | 0.02% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,094,208 | $1,479,000 | 0.02% |
Harel Insurance Investments & Financial Services Ltd. | 1,176,401 | $831,000 | 0.02% |
Atom Investors LP | 113,151 | $80,000 | 0.01% |
Virtu Financial LLC | 130,270 | $91,000 | 0.01% |
Altshuler Shaham Ltd | 1,157,540 | $828,000 | 0.01% |